SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-18-016406
Filing Date
2018-05-04
Accepted
2018-05-04 17:54:29
Documents
2
Period of Report
2018-05-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3397
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY- KARABELAS doc1.txt EX-24 3486
  Complete submission text file 0001127602-18-016406.txt   8353
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
KARABELAS ARGERIS N (Reporting) CIK: 0001191229 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 18809193